Teyi Pharmaceutical Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
April 27, 2022 at 01:14 pm IST
Share
Teyi Pharmaceutical Group Co.,Ltd reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 194.35 million compared to CNY 194.38 million a year ago. Revenue was CNY 194.35 million compared to CNY 194.38 million a year ago. Net income was CNY 45.67 million compared to CNY 41.67 million a year ago. Basic earnings per share from continuing operations was CNY 0.21 compared to CNY 0.2 a year ago. Diluted earnings per share from continuing operations was CNY 0.2 compared to CNY 0.2 a year ago.
TEYI PHARMACEUTICAL GROUP CO., LTD, formerly Guangdong Taicheng Pharmaceutical Co., Ltd., is principally engaged in the production and sale of pharmaceuticals. The Company primarily provides Chinese traditional patent medicines, including cough arresting and phlegm removing medicine series, kidney reinforcing medicine series and anti-infection medicine series, among others. The Company's products mainly include tablets, granules, medicinal tea, syrup, decocted extracts, capsules, powder, ointment, cream, as well as oral solutions, among others.